183 related articles for article (PubMed ID: 32469193)
1. A transgender man, a cisgender woman, and assisted reproductive technologies: a Brazilian case report.
Resende SS; Kussumoto VH; Arima FHC; Krul PC; Rodovalho NCM; Sampaio MRJ; Alves MM
JBRA Assist Reprod; 2020 Oct; 24(4):513-516. PubMed ID: 32469193
[TBL] [Abstract][Full Text] [Related]
2. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.
Amir H; Yaish I; Samara N; Hasson J; Groutz A; Azem F
J Assist Reprod Genet; 2020 Oct; 37(10):2463-2472. PubMed ID: 32719977
[TBL] [Abstract][Full Text] [Related]
3. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
4. Successful In Vitro Fertilization in a Cisgender Female Carrier Using Oocytes Retrieved From a Transgender Man Maintained on Testosterone.
Greenwald P; Dubois B; Lekovich J; Pang JH; Safer J
AACE Clin Case Rep; 2022; 8(1):19-21. PubMed ID: 35097196
[TBL] [Abstract][Full Text] [Related]
5. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine.
Leung A; Sakkas D; Pang S; Thornton K; Resetkova N
Fertil Steril; 2019 Nov; 112(5):858-865. PubMed ID: 31594633
[TBL] [Abstract][Full Text] [Related]
6. Ovarian stimulation for fertility preservation or family building in a cohort of transgender men.
Adeleye AJ; Cedars MI; Smith J; Mok-Lin E
J Assist Reprod Genet; 2019 Oct; 36(10):2155-2161. PubMed ID: 31435820
[TBL] [Abstract][Full Text] [Related]
7. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study.
Sydow P; Gmeinwieser N; Pribbernow K; Keck C; Wiegratz I
Reprod Biol Endocrinol; 2020 May; 18(1):54. PubMed ID: 32456636
[TBL] [Abstract][Full Text] [Related]
9. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
[TBL] [Abstract][Full Text] [Related]
10. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
11. Similar fertilization rates and preimplantation embryo development among testosterone-treated transgender men and cisgender women.
Israeli T; Preisler L; Kalma Y; Samara N; Levi S; Groutz A; Azem F; Amir H
Reprod Biomed Online; 2022 Sep; 45(3):448-456. PubMed ID: 35725536
[TBL] [Abstract][Full Text] [Related]
12. First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization.
Beckers NG; Macklon NS; Devroey P; Platteau P; Boerrigter PJ; Fauser BC
Fertil Steril; 2003 Mar; 79(3):621-3. PubMed ID: 12620451
[TBL] [Abstract][Full Text] [Related]
13. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
14. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
[No Abstract] [Full Text] [Related]
15. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.
Kinnear HM; Constance ES; David A; Marsh EE; Padmanabhan V; Shikanov A; Moravek MB
Hum Reprod; 2019 Oct; 34(10):2009-2017. PubMed ID: 31585007
[TBL] [Abstract][Full Text] [Related]
16. Oocyte retrieval outcomes among adolescent transgender males.
Amir H; Oren A; Klochendler Frishman E; Sapir O; Shufaro Y; Segev Becker A; Azem F; Ben-Haroush A
J Assist Reprod Genet; 2020 Jul; 37(7):1737-1744. PubMed ID: 32430731
[TBL] [Abstract][Full Text] [Related]
17. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
Cavagna M; Maldonado LG; de Souza Bonetti TC; de Almeida Ferreira Braga DP; Iaconelli A; Borges E
Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
[TBL] [Abstract][Full Text] [Related]
19. The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction.
Zafeiriou S; Loutradis D; Michalas S
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):157-67. PubMed ID: 10943580
[TBL] [Abstract][Full Text] [Related]
20. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
